Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Randomized, Study of the Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP)
Conditions
Interventions
human retinal progenitor cells
Mock injection
Locations
3
United States
Gavin Herbert Eye Inst, Univ Cal Irvine
Irvine, California, United States
Retina-Vitreous Associates Medical Group
Los Angeles, California, United States
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
Start Date
March 1, 2017
Primary Completion Date
November 13, 2020
Completion Date
November 13, 2020
Last Updated
June 18, 2024
NCT05926583
NCT07174726
NCT07292987
NCT06789445
NCT04639635
NCT06628947
Lead Sponsor
jCyte, Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions